C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2608359
The disclosure relates to identifying deregulated pathways in cancer. In certain embodiments, the methods of the disclosure can be used to evaluate therapeutic agents for the treatment of cancer.
L'invention concerne l'identification de mécanismes dérégulés dans le cancer. Dans certains modes de réalisation, les méthodes de l'invention peuvent être utilisé pour évaluer des agents thérapeutiques destinés au traitement du cancer.
Berchuck Andrew
Bild Andrea H.
Chang Jeffrey T.
Dressman Holly
Harpole David
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Duke University
University Of South Florida
LandOfFree
Gene expression signatures for oncogenic pathway deregulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gene expression signatures for oncogenic pathway deregulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene expression signatures for oncogenic pathway deregulation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2074019